Filtered By:
Specialty: Internal Medicine
Drug: Coumadin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 131 results found since Jan 2013.
In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level
Ann Intern Med. 2023 Aug 1. doi: 10.7326/J23-0054. Online ahead of print.ABSTRACTHarrington J, Carnicelli AP, Hua K, et al. Direct oral anticoagulants versus warfarin across the spectrum of kidney function: patient-level network meta-analyses from COMBINE AF. Circulation. 2023;147:1748-1757. 37042255.PMID:37523701 | DOI:10.7326/J23-0054
Source: Annals of Internal Medicine - July 31, 2023 Category: Internal Medicine Authors: Stephanie Carlin James Douketis Source Type: research
Warfarin-induced isolated spontaneous subarachnoid hemorrhage: Rare case report
CONCLUSION: Warfarin is rarely associated with isolated subarachnoid hemorrhage. This case highlights a young male patient with spontaneous SAH after warfarin therapy for acute ischemic stroke. Aneurysmal rupture and trauma should be excluded before a diagnosis of warfarin-induced SAH is made.PMID:36582886 | PMC:PMC9793204 | DOI:10.1016/j.amsu.2022.104946
Source: Annals of Medicine - December 30, 2022 Category: Internal Medicine Authors: Mohamed Sheikh Hassan Ahmet Bakir Bakar Ali Adam Nor Osman Sidow Abdiwahid Ahmed Ibrahim Ishak Ahmed Abdi Mohamud Mire Waberi Source Type: research
Clinical profile and risk factors of cerebral venous sinus thrombosis (CVST) in Sudan: A multicenter cross-sectional study
CONCLUSION: Cerebral Venous Sinus Thrombosis is mainly a disease of child-bearing women, although significant proportions of men were affected. Cerebral Venous Sinus Thrombosis presents in a wide variety of signs and symptoms.PMID:36536723 | PMC:PMC9758368 | DOI:10.1016/j.amsu.2022.104891
Source: Annals of Medicine - December 20, 2022 Category: Internal Medicine Authors: Etedal Ahmed A Ibrahim Rofiedah Eisa Hassan Mohamed Khabab Abbasher Hussien Mohamed Ahmed Mazin S Haroun Yassin Abdelrahim Abdalla Mohammed Eltahier Abdalla Omer Mohammed Mahmmoud Fadelallah Eljack Source Type: research
Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study
CONCLUSIONS: Over 12 months after initiation, apixaban and dabigatran conferred progressive increases in event free time for stroke/SE and MB vs warfarin, whereas rivaroxaban conferred an increase in stroke/SE-free time but a loss in MB-free time vs warfarin.PMID:36456387 | DOI:10.1016/j.ejim.2022.10.021
Source: European Journal of Internal Medicine - December 1, 2022 Category: Internal Medicine Authors: Steven Deitelzweig Allison Keshishian Amiee Kang Aaron Jenkins Nipun Atreja Patricia Schuler Jenny Jiang Huseyin Yuce Xiaoxi Sun Gregory Y H Lip Source Type: research
